CAMBRIDGE, England--(BUSINESS WIRE)--Today 10th January 2013, Isogenica, Cambridge UK and Distributed Bio, San Francisco CA enter into a licence agreement to make next generation antibody libraries available to the life science industry. Distributed Bio’s next generation library designs encode years of protein bioengineering and iterative learning, optimised for important characteristics such as stability and immunogenicity, and are designed to provide highly functional antibody libraries with minimal optimisation needs. These libraries will be manufactured using Isogenica’s ColibraTM technology allowing the synthesis of highly specific, ratio controlled, gene libraries which retain the integrity of library designs and maximise the probability of finding good quality leads. Isogenica will offer these libraries for discovery projects using either non-proprietary or proprietary selection technologies such as CIS display.
